Cost-utility analysis of stratified isoniazid dosing by NAT2 genotype compared with isoniazid standard regimen for new patients with pulmonary tuberculosis in Thailand

泰国肺结核新发患者按NAT2基因型分层异烟肼剂量方案与异烟肼标准方案的成本效益分析